Advisory on ‘Cashless Everywhere’ issued by IMA, Hospital Board of India

The Indian Medical Association (IMA) and Hospital Board of India (HBI) have jointly released an advisory regarding the ‘Cashless Everywhere’ program initiated by the General Insurance Corporation (GIC), voicing the medical sector’s apprehensions about its vague details and potential effects. The announcement, made by Dr. AK Ravikumar, head of IMA HBI HORS, pointed out the program’s launch without fully resolving the IMA HBI’s issues, particularly the lack of precise guidelines for its execution.

For more news & updates, check out the link given below:

https://medicaldialogues.in/

Powered by WPeMatico

NEET 2024: Exam pattern for MBBS entrance test

It is crucial to understand the exam pattern to prepare for the prestigious MBBS entrance test- NEET. This year’s NEET 2024 is scheduled to be held on May 5, 2024.

In its recently released information bulletin along with the application form, the National Testing Agency (NTA), the exam conducting body for NEET, has specified the exam pattern.

For the full story, check out the link given below:

Applying For NEET 2024? Understand Exam Pattern For The MBBS Entrance Test

Powered by WPeMatico

Age when periods first start and early menopause linked to heightened COPD risk

A range of reproductive factors, including the age when periods first start and early menopause, are all linked to a heightened risk of COPD—the umbrella term for progressive lung conditions that cause breathing difficulties—finds research published online in the journal Thorax.

Powered by WPeMatico

Poor quality clinical data informing NICE decisions on treatments in over half of cases

The quality of evidence submitted to the National Institute for Health and Care Excellence (NICE) for informing its decisions to recommend technologies for use in the NHS was poor in more than half of cases, reveals a 20-year analysis published in the open access journal BMJ Open.

Powered by WPeMatico

Acupuncture may curb heightened risk of stroke associated with rheumatoid arthritis

A course of acupuncture may curb the heightened risk of stroke associated with rheumatoid arthritis, finds a comparative study published in the open access journal BMJ Open.

Powered by WPeMatico

New digital therapy reduces anxiety and depression in people living with long-term physical health conditions

A therapist-guided digital cognitive behavioral therapy reduced distress in 89% of participants living with long-term physical health conditions, a new King’s College London study finds. The findings appear in Psychological Medicine.

Powered by WPeMatico

Menopause and migraines: New findings point to power of prevention

For middle-aged women plagued by migraines, or hot flashes and night sweats, another worry may linger in the backs of their minds: whether these experiences have set them up for a heart attack, a stroke or another cardiovascular crisis.

Powered by WPeMatico

Committe to address grievances, demands of doctors: Himachal CM Sukhu

Shimla: Himachal Pradesh Chief Minister Sukhvinder Singh Sukhu has given directions for constituting a committee under the chairmanship of Special Secretary (Health) to look into the grievances and demands of the medical officers of the state. 

The Committee will comprise of Director Health and Family Welfare, Director, Medical Education and representatives of the Medical Officers Association. He said that this committee would also study the various aspects of promotions of the doctors and recommend guidelines for the betterment of medical officers.

The Chief Minister said that the State Government was considering all their genuine demands sympathetically, but the financial condition of the State is precarious, a release said.

Also Read:North Bengal Medical College and hospital gets Duarey Council for healthcare grievances

Due to the efforts of the state government, the economy of the state is coming back on the track gradually, he said.

“My Government will surely provide the financial benefits of the government employees in due course,” he assured. The Chief Minister urged the doctors to cooperate with the State Government and assist in improving the economy of the State.

Chief Minister said that they are focusing to strengthen the health infrastructure in the State to provide specialized health services to the people at their doorsteps.

The Government is setting up Adarsh Swasthya Sansthans in all 68 assembly constituencies of the state, with six specialist doctors in each.

To meet shortage of doctors and para-medical staff in health institutions, the State Government is recruiting new medical officers and supporting staff.

Plans are underway to improve working conditions in health institutions and introduce fixed eight-hour shift for medical personnel, the release said.

The Chief Minister said that overseas exposure visits would also be conducted for the doctors on the latest techniques and skills in health care sector. He directed the Health Department to digitize the data of medical officers to streamline their functioning.

Also Read:56 hospitals to be soon digitized under Health Information Management System: Himachal Pradesh CM

Powered by WPeMatico

Lupin unveils Bromfenac Ophthalmic Solution, 0.075% in US

Mumbai: Global pharma major Lupin Limited has announced
the launch of Bromfenac Ophthalmic Solution, 0.075%, after having received an approval from the
United States Food and Drug Administration (U.S. FDA).

Bromfenac Ophthalmic Solution, 0.075% is a generic equivalent of BromSite Ophthalmic Solution,
0.075%, of Sun Pharmaceutical Industries Limited.
It is indicated for the treatment of postoperative
inflammation and prevention of ocular pain in patients undergoing cataract surgery.
Bromfenac Ophthalmic Solution 0.075% (RLD BromSite) had estimated annual sales of USD 15 million
in the U.S. (IQVIA MAT December 2023).
Read also: Lupin bags USFDA nod for Bromfenac Ophthalmic Solution, 0.075%
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The
Company develops and commercializes a wide range of branded and generic formulations, biotechnology
products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin
America (LATAM), Europe, and Middle East regions.
The Company specializes in the cardiovascular, anti-diabetic, and respiratory segments and has
a significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS), and women’s
health areas. The company
invested 7.9% of its revenue in research and development in FY23.
Lupin has 15 manufacturing sites, 7 research centers.
Read also: Lupin posts bigger-than-expected rise in Q3 profit

Powered by WPeMatico

Glutamate Infusion Reduces Kidney Injury After Cardiac Surgery: JAMA

A recent study published in the Journal of American Medical Association unveiled promising results regarding the prevention of acute kidney injury (AKI) following cardiac surgery. This study explored the potential benefits of utilizing glutamate infusion during coronary artery bypass graft (CABG) procedures. 

Acute kidney injury (AKI) is a serious complication associated with cardiac surgery that contributes to increased morbidity and mortality rates among patients. Despite numerous attempts to reduce this risk, success rate has been limited. Thereby, GLUTAMICS (Glutamate for Metabolic Intervention in Coronary Surgery) study pooled data from two prospective, randomized, double-blind multicenter trials and was conducted across five cardiac surgery centers in Sweden. The trials spanned from 2005 to 2020 and included a total of 791 patients without diabetes who were undergoing CABG surgery.

During the procedure, patients received either intravenous infusion of l-glutamic acid or saline. The results found that patients who received glutamate infusion expressed a significantly lower risk of AKI with a relative risk reduction of 51% when compared to the control group. Also, the need for dialysis post-surgery was significantly lower in the glutamate group.

The study emphasized the importance of these findings by highlighting that glutamate infusion represents a potentially transformative approach to AKI prevention in cardiac surgery patients. While further research is mandated to validate these results, the positive implications for patient care are profound from this research.

Globally, cardiac surgeons and medical professionals are optimistic about the implications of this study. If confirmed in future trials, glutamate infusion could become a standard intervention for patients against AKI during CABG procedures which ultimately improve the patient outcomes and reduce healthcare burdens.

Source:

Holm, J., Vanky, F., & Svedjeholm, R. (2024). Association of Glutamate Infusion With Risk of Acute Kidney Injury After Coronary Artery Bypass Surgery. In JAMA Network Open (Vol. 7, Issue 1, p. e2351743). American Medical Association (AMA). https://doi.org/10.1001/jamanetworkopen.2023.51743

Powered by WPeMatico